Variant report
Variant | nsv971187 |
---|---|
Chromosome Location | chr7:126090098-126101043 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:64)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BCLAF1 | chr7:126090272-126090898 | GM12878 | blood: | n/a | n/a |
2 | BCLAF1 | chr7:126090235-126090798 | GM12878 | blood: | n/a | n/a |
3 | BHLHE40 | chr7:126089835-126090907 | GM12878 | blood: | n/a | n/a |
4 | BRCA1 | chr7:126090538-126090546 | GM12878 | blood: | n/a | n/a |
5 | CCNT2 | chr7:126099340-126099539 | K562 | blood: | n/a | n/a |
6 | CEBPB | chr7:126100594-126100794 | H1-hESC | embryonic stem cell: | n/a | chr7:126100653-126100666 chr7:126100655-126100664 chr7:126100653-126100664 chr7:126100655-126100666 |
7 | CEBPB | chr7:126100511-126100809 | IMR90 | lung: | n/a | chr7:126100653-126100666 chr7:126100655-126100664 chr7:126100653-126100664 chr7:126100655-126100666 |
8 | CEBPB | chr7:126100471-126100834 | HepG2 | liver: | n/a | chr7:126100653-126100666 chr7:126100655-126100664 chr7:126100653-126100664 chr7:126100655-126100666 |
9 | CEBPB | chr7:126100510-126100809 | K562 | blood: | n/a | chr7:126100653-126100666 chr7:126100655-126100664 chr7:126100653-126100664 chr7:126100655-126100666 |
10 | CHD1 | chr7:126089898-126091153 | GM12878 | blood: | n/a | n/a |
11 | CHD2 | chr7:126089964-126090744 | GM12878 | blood: | n/a | n/a |
12 | EBF1 | chr7:126090251-126090866 | GM12878 | blood: | n/a | n/a |
13 | EBF1 | chr7:126095231-126095247 | GM12878 | blood: | n/a | n/a |
14 | ELF1 | chr7:126090315-126090713 | GM12878 | blood: | n/a | chr7:126090571-126090582 |
15 | EP300 | chr7:126090040-126091318 | GM12878 | blood: | n/a | chr7:126090622-126090636 |
16 | EP300 | chr7:126090280-126090687 | GM12878 | blood: | n/a | chr7:126090622-126090636 |
17 | EP300 | chr7:126089804-126091145 | GM12878 | blood: | n/a | chr7:126090622-126090636 |
18 | GATA2 | chr7:126089833-126090121 | SH-SY5Y | brain: | n/a | n/a |
19 | MAFK | chr7:126099978-126100011 | HepG2 | liver: | n/a | chr7:126099990-126100005 chr7:126099992-126100001 |
20 | MAFK | chr7:126099988-126100021 | HepG2 | liver: | n/a | chr7:126099990-126100005 chr7:126099992-126100001 |
21 | MAX | chr7:126090243-126091347 | GM12878 | blood: | n/a | chr7:126090390-126090403 chr7:126090392-126090401 chr7:126090390-126090403 chr7:126090391-126090402 |
22 | MEF2A | chr7:126090266-126090889 | GM12878 | blood: | n/a | chr7:126090682-126090697 |
23 | MTA3 | chr7:126090071-126090816 | GM12878 | blood: | n/a | n/a |
24 | MXI1 | chr7:126089861-126091207 | GM12878 | blood: | n/a | n/a |
25 | MYC | chr7:126097677-126097774 | H1-hESC | embryonic stem cell: | n/a | n/a |
26 | NFE2 | chr7:126090274-126090474 | GM12878 | blood: | n/a | chr7:126090392-126090401 |
27 | NFIC | chr7:126090200-126091065 | GM12878 | blood: | n/a | n/a |
28 | NFIC | chr7:126090255-126090859 | GM12878 | blood: | n/a | n/a |
29 | NFYB | chr7:126090075-126090934 | GM12878 | blood: | n/a | chr7:126090487-126090500 |
30 | POLR2A | chr7:126090130-126090706 | GM12878 | blood: | n/a | n/a |
31 | POLR2A | chr7:126093214-126093560 | H1-neurons | neurons: | n/a | n/a |
32 | POLR2A | chr7:126090365-126090629 | GM12878 | blood: | n/a | n/a |
33 | POLR2A | chr7:126090192-126090811 | GM12892 | blood: | n/a | n/a |
34 | POLR2A | chr7:126098974-126099154 | MCF10A-Er-Src | breast: | n/a | n/a |
35 | POLR2A | chr7:126098217-126098401 | MCF10A-Er-Src | breast: | n/a | n/a |
36 | POLR2A | chr7:126095893-126095897 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | POLR2A | chr7:126095114-126095298 | K562 | blood: | n/a | n/a |
38 | POLR2A | chr7:126090970-126091131 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | POLR2A | chr7:126090470-126090613 | GM12878 | blood: | n/a | n/a |
40 | POLR2A | chr7:126090148-126090713 | Raji | blood: | n/a | n/a |
41 | POU2F2 | chr7:126090249-126090754 | GM12891 | blood: | n/a | chr7:126090496-126090508 chr7:126090497-126090507 chr7:126090497-126090507 chr7:126090496-126090509 chr7:126090498-126090507 chr7:126090496-126090510 |
42 | POU2F2 | chr7:126090207-126090768 | GM12878 | blood: | n/a | chr7:126090496-126090508 chr7:126090497-126090507 chr7:126090497-126090507 chr7:126090496-126090509 chr7:126090498-126090507 chr7:126090496-126090510 |
43 | POU2F2 | chr7:126090369-126090690 | GM12878 | blood: | n/a | chr7:126090496-126090508 chr7:126090497-126090507 chr7:126090497-126090507 chr7:126090496-126090509 chr7:126090498-126090507 chr7:126090496-126090510 |
44 | POU2F2 | chr7:126090375-126090642 | GM12891 | blood: | n/a | chr7:126090496-126090508 chr7:126090497-126090507 chr7:126090497-126090507 chr7:126090496-126090509 chr7:126090498-126090507 chr7:126090496-126090510 |
45 | RCOR1 | chr7:126089872-126090896 | GM12878 | blood: | n/a | n/a |
46 | RFX5 | chr7:126097219-126097419 | K562 | blood: | n/a | n/a |
47 | RUNX3 | chr7:126090298-126090936 | GM12878 | blood: | n/a | n/a |
48 | RUNX3 | chr7:126090078-126091007 | GM12878 | blood: | n/a | n/a |
49 | SMC3 | chr7:126091077-126091127 | GM12878 | blood: | n/a | n/a |
50 | SP1 | chr7:126090146-126090691 | GM12878 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
GRM8 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs567281051 | chr7:126090122-126090123 | Enhancers Flanking Active TSS Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs12706731 | chr7:126090189-126090190 | Enhancers Flanking Active TSS Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs193112669 | chr7:126090227-126090228 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs574535658 | chr7:126090337-126090338 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs571472264 | chr7:126090430-126090431 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs538564766 | chr7:126090441-126090442 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs184590430 | chr7:126090443-126090444 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs572268207 | chr7:126090449-126090450 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs13247338 | chr7:126090509-126090510 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs555085489 | chr7:126090519-126090520 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs368522820 | chr7:126090531-126090532 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs17679839 | chr7:126090571-126090572 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs558687008 | chr7:126090585-126090586 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs577427954 | chr7:126090589-126090590 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs71576278 | chr7:126090595-126090596 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs541319043 | chr7:126090620-126090621 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs73442988 | chr7:126090629-126090630 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs138773238 | chr7:126090657-126090658 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs35311551 | chr7:126090662-126090663 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs566131748 | chr7:126090679-126090680 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs34548667 | chr7:126090680-126090681 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs398111847 | chr7:126090691-126090692 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs141179099 | chr7:126090728-126090729 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs561008333 | chr7:126090856-126090857 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs531309641 | chr7:126090880-126090881 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs371200007 | chr7:126090938-126090939 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs188945096 | chr7:126090956-126090957 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs114578395 | chr7:126090985-126090986 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs546093558 | chr7:126091048-126091049 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs374576757 | chr7:126091071-126091072 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs150721560 | chr7:126091135-126091136 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs139001968 | chr7:126091148-126091149 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs547693554 | chr7:126091180-126091181 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs79686177 | chr7:126091192-126091193 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs2106194 | chr7:126091200-126091201 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs2106195 | chr7:126091218-126091219 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs181385398 | chr7:126091237-126091238 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs563146300 | chr7:126091256-126091257 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs185828859 | chr7:126091258-126091259 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs115481583 | chr7:126091276-126091277 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs537160061 | chr7:126091285-126091286 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs3948750 | chr7:126091301-126091302 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs2106196 | chr7:126091345-126091346 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs11767749 | chr7:126091381-126091382 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs376749560 | chr7:126091505-126091506 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
46 | rs577144032 | chr7:126091525-126091526 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
47 | rs113980103 | chr7:126091567-126091568 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
48 | rs189777011 | chr7:126091695-126091696 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs562791434 | chr7:126091715-126091716 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs574812554 | chr7:126091722-126091723 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19401682 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21509527 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Epilepsy | 21635232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Autism | 20808228 | CNVD |
Autism | 19246517 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Prostate cancer | 22341455 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:126082400-126090200 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
2 | chr7:126088600-126091000 | Enhancers | HSMMtube | muscle |
3 | chr7:126089200-126091000 | Enhancers | Fetal Lung | lung |
4 | chr7:126089800-126090600 | Enhancers | Fetal Intestine Large | intestine |
5 | chr7:126089800-126090600 | Enhancers | NH-A | brain |
6 | chr7:126089800-126091000 | Enhancers | Duodenum Smooth Muscle | Duodenum |
7 | chr7:126089800-126091400 | Flanking Active TSS | GM12878-XiMat | blood |
8 | chr7:126090000-126090400 | Flanking Active TSS | Fetal Heart | heart |
9 | chr7:126090200-126090600 | Enhancers | Rectal Mucosa Donor 31 | rectum |
10 | chr7:126090400-126091400 | Enhancers | Fetal Heart | heart |
11 | chr7:126091400-126091600 | ZNF genes & repeats | GM12878-XiMat | blood |